Anuja Jhingran, M.D., FASTRO, FACR

Peer-Reviewed Articles

1. Court, K, Teka, B, Cisneros-Napravnik, T, Karpinets, T, El Alam, MB, Firdawoke, E, Chanyalew, Z, Mihret, A, Addissie, A, Gizaw, M, Lan, J, Haymaker, CL, Duose, D, Luthra, R, Colbert, LE, Jhingran, A, Kantelhardt, EJ, Kaufmann, AM, Abebe, T, Klopp, AH. Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer. JCO Global Oncology 11:e2500060, 2025. e-Pub 2025. PMID: 41435214.
2. Kouzy, R, Rooney, M, Cha, E, Vinjamuri, S, Wu, H, Kouzi, ZE, Mohamad, O, Sims, TT, Weil, CR, Taku, N, Lin, LL, Jhingran, A, Eifel, PJ, Joyner, MM, Colbert, LE, Klopp, AH. AI based sentiment analysis of online discussions related to cervical brachytherapy. Technical Innovations and Patient Support in Radiation Oncology 36, 2025. e-Pub 2025. PMID: 41473390.
3. Rajan, SS, Ning, M, Jacobson, M, Simiele, SJ, Bruno, TL, Kouzy, R, Court, K, Cisneros-Napravnik, T, Yu, H, Stafford, J, Kim, Y, Mathew, GG, Cordova, RA, Domingo, M, Jhingran, A, Lin, LL, Joyner, MM, Sims, TT, Colbert, LE, Venkatesan, AM, Klopp, AH. Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy. Brachytherapy 24(6):844-853, 2025. e-Pub 2025. PMID: 40816920.
4. Gay, SS, Gronberg, M, Mumme, R, Beadle, BM, Jhingran, A, Lim, TY, Yu, ZH, Chung, CV, Khan, M, Pinnix, CC, Shete, S, Parker, B, Netherton, T, Cardenas, CE, Court, LE. Intentional creation of suboptimal, realistic dose distributions. Journal of applied clinical medical physics 26(11), 2025. e-Pub 2025. PMID: 41144809.
5. Rishi, A, Albuquerque, K, Jhingran, A, Donovan, E, Horne, ZD, Ludwig, MS, Pathak, P, Goldsberry, R, Glaser, S, Garg, A, Yin, V, Fernandez, DC, Beriwal, S, Ahmed, K, Montejo, M. Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer. Gynecologic oncology 199:1-9, 2025. e-Pub 2025. PMID: 40513383.
6. Marquez, B, Fuentes, DA, Peterson, CB, Rhee, DJ, Douglas, RJ, Mumme, R, Jhingran, A, Pollard-Larkin, JM, Prajapati, S, Whitaker, TJ, Court, LE. Automatic contour quality assurance using deep-learning based contours. Physics in medicine and biology 70(14), 2025. e-Pub 2025. PMID: 40532726.
7. Ahmed, J, Knisely, A, Torrado, C, Stephen, B, Yang, Y, Song, J, Alshawa, A, Zarifa, A, Jhingran, A, Koay, EJ, Morris, VK, Javle, M, Wolff, RA, Meric-Bernstam, F, Pant, S, Rodon Ahnert, J, Naing, A. A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies. Oncologist 30(3), 2025. e-Pub 2025. PMID: 40139261.
8. Chung CV, Khan MS, Olanrewaju A, Pham M, Nguyen QT, Patel T, Das P, O'Reilly MS, Reed VK, Jhingran A, Simonds H, Ludmir EB, Hoffman KE, Naidoo K, Parkes J, Aggarwal A, Mayo LL, Shah SJ, Tang C, Beadle BM, Wetter J, Walker G, Hughes S, Mullassery V, Skett S, Thomas C, Zhang L, Nguyen S, Mumme RP, Douglas RJ, Baroudi H, Court LE. Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites. Radiother Oncol 202:110609, 2025. e-Pub 2025. PMID: 39486482.
9. Seo A, Xiao W, Gjyshi O, Yoshida-Court K, Wei P, Swanson D, Cisneros Napravnik T, Grippin A, Venkatesan AM, Jacobsen MC, Fuentes DT, Lynn E, Sammouri J, Jhingran A, Joyner M, Lin LL, Colbert LE, Gillison ML, Klopp AH. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation. Clinical Cancer Research 31(4):697-706, 2024. e-Pub 2024. PMID: 39680029.
10. DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, Small W Jr, Suneja G, Gaffney D. Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol 14(6):e500-e506, 2024. e-Pub 2024. PMID: 39269405.
11. Marquez B, Wooten ZT, Salazar RM, Peterson CB, Fuentes DT, Whitaker TJ, Jhingran A, Pollard-Larkin J, Prajapati S, Beadle B, Cardenas CE, Netherton TJ, Court LE. Analyzing the Relationship between Dose and Geometric Agreement Metrics for Auto-Contouring in Head and Neck Normal Tissues. Diagnostics (Basel) 14(15), 2024. e-Pub 2024. PMID: 39125508.
12. Andring LM, Corrigan KL, Reeve B, Meyer L, Wang XS, Smith G, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. The value of patient-reported outcomes to predict for symptom burden and health-related quality of life after chemoradiation for cervical cancer: A prospective study. Practical radiation oncology 14(5):e353-e361, 2024. e-Pub 2024. PMID: 38825227.
13. Ludmir EB, Hoffman KE, Jhingran A, Kouzy R, Ip MP, Sturdevant L, Ning MS, Minsky BD, McAleer MF, Chronowski GM, Arzu IY, Reed VK, Garg AK, Roberts T, Eastwick GA, Olson MR, Selek U, Gabel M, Koong AC, Kupferman ME, Kuban DA. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network. Pract Radiat Oncol 14(3):e173-e179, 2024. e-Pub 2024. PMID: 38176466.
14. Court LE, Aggarwal A, Jhingran A, Naidoo K, Netherton T, Olanrewaju A, Peterson C, Parkes J, Simonds H, Trauernicht C, Zhang L, Beadle BM. Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care. JCO Glob Oncol 10:e2300376, 2024. e-Pub 2024. PMID: 38484191.
15. Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH, Colbert LE. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy 23(2):123-135, 2024. e-Pub 2024. PMID: 38129211.
16. Khurana N, Frumovitz M, Flores Legarreta A, Ramalingam P, Jhingran A, Bhosale P, Saab R, Gonzales NRR, Chisholm GB, Salvo G. Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study. Int J Gynecol Cancer 34(2):209-215, 2024. e-Pub 2023. PMID: 38101814.
17. Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2024. PMID: 37914588.
18. Sammouri J, Venkatesan AM, Lin LL, Jhingran A, Klopp AH, Joyner MM, Eifel PJ, Colbert LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecol Oncol 180:24-34, 2024. e-Pub 2024. PMID: 38041900.
19. Rios-Doria E, Cun HT, Filippova OT, Mueller JJ, Alektiar KM, Ellenson LH, Makker V, Lakhman Y, Leitao MM, Jhingran A, Soliman PT, Abu-Rustum NR. Isolated vaginal recurrence in women with stage I endometrial cancer. Gynecol Oncol 179:9-15, 2023. e-Pub 2023. PMID: 37864854.
20. Gay SS, Kisling KD, Anderson BM, Zhang L, Rhee DJ, Nguyen C, Netherton T, Yang J, Brock K, Jhingran A, Simonds H, Klopp A, Beadle BM, Court LE, Cardenas CE. Identifying the optimal deep learning architecture and parameters for automatic beam aperture definition in 3D radiotherapy. J Appl Clin Med Phys 24(12):e14131, 2023. e-Pub 2023. PMID: 37670488.
21. Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, Sims T, Delgado Medrano AY, Napravnik TC, O'Hara M, Lin D, Abana CO, Li HX, Eifel PJ, Jhingran A, Joyner M, Lin L, Ramondetta LM, Futreal AM, Schmeler KM, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami NJ, Wong M, Taniguchi C, Petrosino JF, Sastry KJ, Okhuysen PC, Martinez SA, Tan L, Mahmud I, Lorenzi PL, Wargo JA, Klopp AH. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell 41(11):1945-1962.e11, 2023. e-Pub 2023. PMID: 37863066.
22. Frumovitz M, Morani AC, Aziz A, Jhingran A, Ramalingam P, Gonzales NR, Salvo G, Sun J, Bhosale P. PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer 33(11):1690-1694, 2023. e-Pub 2023. PMID: 37875320.
23. Andring LM, Corrigan KL, Rooney M, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Kazantsev T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. Patient reported outcomes for women undergoing definitive chemoradiation for gynecologic cancer: A prospective clinical trial. Pract Radiat Oncol 13(6):e538-e546, 2023. e-Pub 2023. PMID: 37597615.
24. Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, Small W, Kudchadker RJ, Swamidas J, Chopra S, Rai B, Sharma SD, Sharma DN, Kuppusamy T, Yang R, Berger D, Mendez LC, Glaser S, Erickson DL, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U. The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy 22(6):716-727, 2023. e-Pub 2023. PMID: 37704540.
25. Court LE, Aggarwal A, Burger H, Cardenas C, Chung C, Douglas R, du Toit M, Jhingran A, Mumme R, Muya S, Naidoo K, Ndumbalo J, Netherton T, Nguyen C, Olanrewaju A, Parkes J, Shaw W, Trauernicht C, Xu M, Yang J, Zhang L, Simonds H, Beadle BM. Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources. J Vis Exp 2023(200), 2023. e-Pub 2023. PMID: 37870317.
26. Saab RH, Salvo G, Gonzales NR, Munsell MF, Shinn EH, Jhingran A, Bhosale P, Ramalingam P, Frumovitz M. Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study. Gynecol Oncol 177:95-102, 2023. e-Pub 2023. PMID: 37657194.
27. Gronberg MP, Jhingran A, Netherton TJ, Gay SS, Cardenas CE, Chung C, Fuentes D, Fuller CD, Howell RM, Khan M, Lim TY, Marquez B, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep learning-based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Med Phys. e-Pub 2023. PMID: 37706560.
28. Salvo G, Flores Legarreta A, Ramalingam P, Jhingran A, Bhosale P, Saab R, Gonzales NR, Chisholm GB, Frumovitz M. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer 33(9):1359-1369, 2023. e-Pub 2023. PMID: 37567596.
29. Kunz JN, Huang YJ, Casper AC, Suneja G, Burt LM, Jhingran A, Joyner MM, Harkenrider MM, Small W, Grant JD, Kidd EA, Boucher K, Gaffney DK. Dosimetric Evaluation of OARs from SAVE Protocol. Int J Radiat Oncol Biol Phys 117(1):274-280, 2023. e-Pub 2023. PMID: 37023988.
30. Gronberg MP, Beadle BM, Garden AS, Skinner H, Gay S, Netherton T, Cao W, Cardenas CE, Chung C, Fuentes DT, Fuller CD, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Pract Radiat Oncol 13(3):e282-e291, 2023. e-Pub 2023. PMID: 36697347.
31. Teka, B, Court, K, Firdawoke, E, Chanyalew, Z, Gizaw, M, Addissie, A, Mihret, A, Colbert, LE, Napravnik, TC, El Alam, MB, Lynn, EJ, Mezzari, MP, Jhingran, A, Kantelhardt, EJ, Kaufmann, AM, Klopp, AH, Abebe, T. Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women. Microorganisms 11(4), 2023. e-Pub 2023. PMID: 37110255.
32. Frumovitz M, Chisholm GB, Jhingran A, Ramalingam P, Flores-Legarreta A, Bhosale P, Gonzales NR, Hillman RT, Slavo G. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am J Obstet Gynecol 228(4):445.e1-445.e8, 2023. e-Pub 2022. PMID: 36516952.
33. Kim C, Salvo G, Ishikawa M, Chen TC, Jhingran A, Bhosale P, Ramalingam P, Frumovitz M. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol Oncol 170:328-332, 2023. e-Pub 2023. PMID: 36773379.
34. Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39:100578, 2023. e-Pub 2023. PMID: 36935860.
35. Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2023. PMID: 36494250.
36. Sherertz T, Jhingran A, Biagioli M, Gaffney D, Elshaikh M, Coleman RL, Harkenrider M, Kidd EA, Jolly S, Yashar C, Portelance L, Wahl A, Venkatesan A, Li L, Small W, Society AR. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. Int J Gynecol Cancer 32(12):1549-1554, 2022. e-Pub 2022. PMID: 36423958.
37. Sherry AD, Bathala TK, Liu S, Fellman BM, Chun SG, Jasani N, Guadagnolo BA, Jhingran A, Reddy JP, Corn PG, Shah AY, Kaiser KW, Ghia AJ, Gomez DR, Tang C. Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results from the Lead-In Phase of the Randomized Basket Trial EXTEND. Int J Radiat Oncol Biol Phys 114(5):910-918, 2022. e-Pub 2022. PMID: 35691448.
38. Mitra D, Farr M, Nagarajan P, Ho J, Bishop AJ, Jhingran A, Farooqi AS, Frumovitz M, Amaria RN, McQuade JL, Jazaeri AA, Guadagnolo BA. Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression. Gynecol Oncol 167(3):483-489, 2022. e-Pub 2022. PMID: 36229264.
39. Kurnit KC, Nobre SP, Fellman BM, Iglesias DA, Lindemann K, Jhingran A, Eriksson AGZ, Ataseven B, Glaser GE, Mueller JJ, Westin SN, Soliman PT. Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecol Oncol 167(3):452-457, 2022. e-Pub 2022. PMID: 36243601.
40. Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol 12(5):e423-e433, 2022. e-Pub 2022. PMID: 35390531.
41. Karpinets TV, Wu X, Solley T, El Alam MB, Sims TT, Yoshida-Court K, Lynn E, Ahmed-Kaddar M, Biegert G, Yue J, Song X, Sun H, Petrosino JF, Mezzari MP, Okhuysen P, Eifel PJ, Jhingran A, Lin LL, Schmeler KM, Ramondetta L, Ajami N, Jenq RR, Futreal A, Zhang J, Klopp AH, Colbert LE. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1):945, 2022. e-Pub 2022. PMID: 36050658.
42. Rhee DJ, Jhingran A, Huang K, Netherton TJ, Fakie N, White I, Sherriff A, Cardenas CE, Zhang L, Prajapati S, Kry SF, Beadle BM, Shaw W, O'Reilly F, Parkes J, Burger H, Trauernicht C, Simonds H, Court LE. Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques. Med Phys 49(9):5742-5751, 2022. e-Pub 2022. PMID: 35866442.
43. Rhee DJ, Akinfenwa CPA, Rigaud B, Jhingran A, Cardenas CE, Zhang L, Prajapati S, Kry SF, Brock KK, Beadle BM, Shaw W, O'Reilly F, Parkes J, Burger H, Fakie N, Trauernicht C, Simonds H, Court LE. Automatic contouring QA method using a deep learning-based autocontouring system. J Appl Clin Med Phys 23(8):e13647, 2022. e-Pub 2022. PMID: 35580067.
44. Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, Castillo P, Hughes N, Mohammadsaid M, Jhingran A, Klopp AH, Choi S, Fuller CD, Lin LL. Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: An R-IDEAL stage 1/2a first in humans/feasibility study of new technology implementation. Pract Radiat Oncol 12(4):e296-e305, 2022. e-Pub 2022. PMID: 35278717.
45. Lakomy DS, Yoder AK, Wu J, Hernandez M, Ayoola-Adeola M, Jhingran A, Klopp A, Soliman P, Peterson SK, Lin LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. Int J Gynecol Cancer 32(10):1266-1275, 2022. e-Pub 2022. PMID: 35680139.
46. Salvo G, Jhingran A, Ramalingam P, Legarreta AF, Bhosale P, Gonzales NR, Chisholm GB, Frumovitz M. Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study. Gynecol Oncol 165(3):530-537, 2022. e-Pub 2022. PMID: 35396134.
47. Lakomy DS, Wu J, Chapman BV, Yu ZH, Lee B, Klopp AH, Jhingran A, Eifel PJ, Lin LL. Use of specific duodenal dose constraints during treatment planning reduces toxicity after definitive para-aortic radiotherapy for cervical cancer. Pract Radiat Oncol 12(3):e207-e215, 2022. e-Pub 2021. PMID: 34958984.
48. Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2021. PMID: 34974906.
49. Gaffney D, Creutzberg CL, Jhingran A. Special Issue: Radiation Oncology in Gynecologic Malignancies. Int J Gynecol Cancer 32(3):215, 2022. e-Pub 2022. PMID: 35256405.
50. Colbert LE, Alam MBE, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
51. Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. The radiotherapy quality assurance gap among phase III cancer clinical trials. Radiother Oncol 166:51-57, 2022. e-Pub 2021. PMID: 34838891.
52. Anakwenze Akinfenwa CP, Ibraheem A, Nwankwo K, Lasebikan N, Ali-Gombe M, Aliyu UM, Ikhile E, Adegboyega O, Abdullahi A, Klopp AH, Schmeler K, Lin LL, Jhingran A, Page BR, Leng J, Grover S, Ntekim A. Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria. JCO Glob Oncol 7:1260-1269, 2021. e-Pub 2021. PMID: 34351813.
53. Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4(1):237, 2021. e-Pub 2021. PMID: 33619320.
54. Salvo G, Ramalingam P, Flores Legarreta A, Jhingran A, Gonzales NR, Chisholm GB, Frumovitz M. Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study. Int J Gynecol Cancer. e-Pub 2021. PMID: 33563641.
55. Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys 109(2):413-424, 2021. e-Pub 2021. PMID: 32905846.
56. Li BC, Chew J, Wakefield DV, Agarwal A, Jhingran A. Frameworks for Radiation Oncology Global Health Initiatives in US Residency Programs. JCO Glob Oncol 7:233-241, 2021. e-Pub 2021. PMID: 33570998.
57. Xu, M, Tapia, C, Hajjar, J, Sabir, SH, Colen, R, Nagarajan, P, Aung, PP, Gong, J, Rodon Ahnert, J, Fu, S, Stephen, B, Roy Chowdhuri, S, Le, H, Yang, V, Zarifa, A, Abdelsalam, ME, Jhingran, A, Javle, M, Pant, S, Carter, B, Milton, D, Sun, R, Karp, DD, Koay, EJ, Yang, Y, Wistuba, II, Hwu, P, Meric-Bernstam, F, Naing, A. Implementation of a novel web-based lesion selection tool to improve acquisition of tumor biopsy specimens. Journal of Immunotherapy and Precision Oncology 4(2):45-52, 2021. e-Pub 2021. PMID: 35663531.
58. El Alam MB, Sims TT, Kouzy R, Biegert GWG, JABI J, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
59. Harkenrider MM, Markham MJ, Dizon DS, Jhingran A, Salani R, Serour RK, Lynn J, Kohn EC. Moving Forward in Cervical Cancer - Enhancing Susceptibility to DNA Repair Inhibition and Damage: NCI Clinical Trials Planning Meeting Report. J Natl Cancer Inst 112(11):1081-1088, 2020. e-Pub 2020. PMID: 32219419.
60. Expert Panel on GYN, Imaging OB, Reinhold C, Ueno Y, Akin EA, Bhosale PR, Dudiak KM, Jhingran A, Kang SK, Kilcoyne A, Lakhman Y, Nicola R, Pandharipande PV, Paspulati R, Shinagare AB, Small W, Vargas HA, Whitcomb BP, Glanc P. ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer. J Am Coll Radiol 17(11S):S472-S486, 2020. e-Pub 2020. PMID: 33153558.
61. Stecklein SR, Taniguchi CM, Melancon AD, Lombe D, Lishimpi K, Banda L, Mwaba C, Pupwe G, Mwale M, Munkupa H, Kanduza M, Mule B, Mwale A, Court L, Ohrt JD, Kupferman ME, Jhingran A, Msadabwe-Chikuni SC. Radiation Sciences Education in Africa: An Assessment of Current Training Practices and Evaluation of a High-Yield Course in Radiation Biology and Radiation Physics. JCO Glob Oncol 6:1631-1638, 2020. e-Pub 2020. PMID: 33108232.
62. Rhee DJ, Jhingran A, Rigaud B, Netherton T, Cardenas CE, Zhang L, Vedam S, Kry S, Brock KK, Shaw W, O'Reilly F, Parkes J, Burger H, Fakie N, Trauernicht C, Simonds H, Court LE. Automatic contouring system for cervical cancer using convolutional neural networks. Med Phys. e-Pub 2020. PMID: 32964477.
63. Scanderbeg DJ, Yashar C, Ouhib Z, Jhingran A, Einck J. Development, implementation, and associated challenges of a new HDR brachytherapy program. Brachytherapy. e-Pub 2020. PMID: 32950407.
64. Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W, Yashar CM, Viswanathan AN. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecol Oncol. e-Pub 2020. PMID: 32563593.
65. Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer 126(11):2607-2613, 2020. e-Pub 2020. PMID: 32125711.
66. Kisling K, Cardenas C, Anderson BM, Zhang J, Jhingran A, Simonds H, Balter P, Howell RM, Schmeler K, Beadle BM, Court L. Automatic verification of beam apertures for cervical cancer radiotherapy. Pract Radiat Oncol. e-Pub 2020. PMID: 32450365.
67. Sapienza LG, Ning MS, de la Pena R, McNew LK, Jhingran A, Georgeon L, Rasool N, Gomes MJL, Abu-Isa E, Baiocchi G. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. Int J Gynecol Cancer. e-Pub 2020. PMID: 32376738.
68. Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemo radiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
69. Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, Jhingran A, Pareja R. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer 30(5):561-563, 2020. e-Pub 2020. PMID: 32221023.
70. Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
71. Armbruster SD, Fellman BM, Jhingran A, Eifel PJ, Klopp AH, Coleman RL, Ramondetta LM, Frumovitz M. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. e-Pub 2020. PMID: 32338316.
72. Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas Carvalho E, Baiocchi G. Pelvic insufficiency fractures after external beam radiotherapy for gynecologic cancers: a meta-analysis and meta-regression of 3,929 patients. Int J Radiat Oncol Biol Phys 106(3):475-484, 2020. e-Pub 2020. PMID: 31580930.
73. Colbert LE, Jhingran A. Immunotherapy and Radiation. Adv Exp Med Biol 1244:205-213, 2020. e-Pub 2020. PMID: 32301016.
74. Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy. e-Pub 2019. PMID: 31786169.
75. Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. e-Pub 2019. PMID: 31500892.
76. Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, Fleming ND. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. Gynecol Oncol 154(2):328-332, 2019. e-Pub 2019. PMID: 31221496.
77. Kassab C, Ramirez PT, Jhingran A, Bhosale P, Broaddus R. Endometrial cancer with cervical extension in an obese patient: options for surgery versus combined chemoradiotherapy and extra-fascial hysterectomy. Int J Gynecol Cancer 29(5):976-980, 2019. e-Pub 2019. PMID: 31155519.
78. Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy. e-Pub 2019. PMID: 31160198.
79. Vorbeck CS, Jhingran A, Iyer RB, Loft A, Klopp A, Mirza MR, Sobremonte A, Vedam S, Vogelius IR. Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer. Int J Gynecol Cancer. e-Pub 2019. PMID: 31126968.
80. Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol. e-Pub 2019. PMID: 31109659.
81. Kisling K, Zhang L, Yang J, Balter PA, Howell RM, Court L, Shaitelman SF, Jhingran A, Anderson D, Thebe T, Schmeler K, Simonds H, du Toit M, Trauernicht C, Burger H, Botha K, Joubert N, Beadle BM. Automated treatment planning of postmastectomy radiotherapy. Med Phys. e-Pub 2019. PMID: 31077593.
82. Kisling K, Johnson JL, Simonds H, Zhang L, Jhingran A, Beadle BM, Burger H, Toit MD, Joubert N, Makufa R, Shaw W, Trauernicht C, Balter P, Howell RM, Schmeler K, Court L. A Risk Assessment of Automated Treatment Planning and Recommendations for Clinical Deployment. Med Phys. e-Pub 2019. PMID: 31002389.
83. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy. e-Pub 2019. PMID: 30992185.
84. Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol 135:58-64. e-Pub 2019. PMID: 31015171.
85. Sapienza LG, Ning MS, Jhingran A, Lin LL, Leão CR, da Silva BB, Pellizzon ACA, Gomes MJL, Baiocchi G. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study. Clin Transl Radiat Oncol 14:40-46, 2019. e-Pub 2019. PMID: 30555940.
86. Kisling K, Zhang L, Simonds H, Fakie N, Yang J, McCarroll R, Balter P, Burger H, Bogler O, Howell R, Schmeler K, Mejia M, Beadle BM, Jhingran A, Court L. Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics. J Glob Oncol(2019):1-9, 2019. e-Pub 2019. PMID: 30629457.
87. Salcedo MP, Sood AK, Dos Reis R, Ramalingam P, Chen C, Frumovitz M, Jhingran A, Pitcher B, Ramirez PT, Schmeler KM. Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. Gynecol Oncol 152(1):101-105, 2019. e-Pub 2019. PMID: 30396690.
88. Sapienza LG, Jhingran A, Kollmeier MA, Lin LL, Calsavara VF, Gomes MJL, Baiocchi G. Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis. Gynecol Oncol 151(3):573-578, 2018. e-Pub 2018. PMID: 30333082.
89. Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
90. Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan AN, Small W. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. Int J Radiat Oncol Biol Phys 101(5):1069-1077, 2018. e-Pub 2018. PMID: 29885996.
91. Ager BJ, Gallardo-Rincón D, de León DC, Chávez-Blanco A, Chuang L, Dueñas-González A, Gómez-García E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Pérez-Plasencia C, Plante M, Poveda A, Gaffney DK. Advancing Clinical Research Globally: Cervical Cancer Research Network from Mexico. Gynecol Oncol Rep 25:90-93, 2018. e-Pub 2018. PMID: 30014021.
92. Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD. Society of Gynecologic Oncology Future of Physician Payment Reform Task Force Report: The Endometrial Cancer Alternative Payment Model (ECAP). Gynecol Oncol 149(2):232-240, 2018. e-Pub 2018. PMID: 29544708.
93. Women’s Imaging: EPO, Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, Maturen KE, Nicola R, Pandharipande PV, Salazar GM, Shipp TD, Simpson L, Small W, Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P. ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer. J Am Coll Radiol 15(5S):S198-S207, 2018. e-Pub 2018. PMID: 29724422.
94. Court LE, Kisling K, McCarroll R, Zhang L, Yang J, Simonds H, du Toit M, Trauernicht C, Burger H, Parkes J, Mejia M, Bojador M, Balter P, Branco D, Steinmann A, Baltz G, Gay S, Anderson B, Cardenas C, Jhingran A, Shaitelman S, Bogler O, Schmeller K, Followill D, Howell R, Nelson C, Peterson C, Beadle B. Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System. J Vis Exp(134), 2018. e-Pub 2018. PMID: 29708544.
95. Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol 148(1):132-138, 2018. e-Pub 2018. PMID: 29089122.
96. Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy 16(6):1129-1143, 2017. e-Pub 2017. PMID: 28888417.
97. McCarroll R, Youssef B, Beadle B, Bojador M, Cardan R, Famiglietti R, Followill D, Ibbott G, Jhingran A, Trauernicht C, Balter P, Court L. Model for Estimating Power and Downtime Effects on Teletherapy Units in Low-Resource Settings. J Glob Oncol 3(5):563-571, 2017. e-Pub 2017. PMID: 29094096.
98. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer. e-Pub 2017. PMID: 28930812.
99. Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol 7(3):e165-e173, 2017. e-Pub 2017. PMID: 27743802.
100. Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys 97(3):546-553, 2017. e-Pub 2017. PMID: 28011045.
101. Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol 143(3):552-557, 2016. e-Pub 2016. PMID: 27645621.
102. Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 96(4):793-800, 2016. e-Pub 2016. PMID: 27788952.
103. Gaffney D, Small B, Kitchener H, Young Ryu S, Viswanathan A, Trimble T, Covens A, Wilailak S, Lertkhachonsuk AA, Sitathanee C, Mahantshetty U, Fisher B, Springer S, Pollatz T, Spiller A, Bacon M, Jhingran A. Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale. Int J Gynecol Cancer 26(9):1690-1693, 2016. e-Pub 2016. PMID: 27779548.
104. Elshaikh MA, Vance S, Gaffney DK, Biagioli M, Jhingran A, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W, Radiation Oncology–Gynecology: EPO. ACR Appropriateness Criteria® Management of Recurrent Endometrial Cancer. Am J Clin Oncol 39(5):507-15, 2016. e-Pub 2016. PMID: 27400117.
105. Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys 95(4):1191-200, 2016. e-Pub 2016. PMID: 27130794.
106. Jhingran A, Klopp A. Big Data to the Rescue: Is there a benefit to combined-modality adjuvant therapy in endometrial cancer?. Gynecol Oncol 141(3):403-4, 2016. e-Pub 2016. PMID: 27210265.
107. Kisling K, Zhang L, Yang J, Jhingran A, Balter P, McCarroll R, Beadle B, Howell R, Schmeler K, Court L. SU-F-T-423: Automating Treatment Planning for Cervical Cancer in Low- and Middle- Income Countries. Med Phys 43(6):3560, 2016. e-Pub 2016. PMID: 28048573.
108. Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-based Peer-review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract 12(4):e476-86, 2016. e-Pub 2016. PMID: 26931402.
109. Jones E, Beriwal S, Beyer D, Chino J, Jhingran A, Lee L, Michalski J, Mundt AJ, Patton C, Petersen I, Portelance L, Schwarz JK, McCloskey S. An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary. Adv Radiat Oncol 1(1):26-34, 2016. e-Pub 2016. PMID: 28799571.
110. Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, McCormack M, Plante M, Casado A, Reuss A, Chávez-Blanco A, Kitchener H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll C, Abu-Rustum NR, Lecuru F, Small W, brainstorming day GCICC. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Int J Gynecol Cancer 26(1):199-207, 2016. e-Pub 2016. PMID: 26569057.
111. Lindau ST, Abramsohn EM, Baron SR, Florendo J, Haefner HK, Jhingran A, Kennedy V, Krane MK, Kushner DM, McComb J, FMerritt DF, Park JE, Siston A, Straub M, Streicher L. Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation wiht a specialist. CA Cancer J Clin, 2016. e-Pub 2016.
112. Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W. ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park) 29(11):867-72, 874-5, 2015. e-Pub 2015. PMID: 26568534.
113. Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A. Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol 5(6):e557-65, 2015. e-Pub 2015. PMID: 26432679.
114. Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol 139(1):40-6, 2015. e-Pub 2015. PMID: 26193429.
115. Cox M, Carmack C, Hughes D, Baum G, Brown J, Jhingran A, Lu K, Basen-Engquist K. Antecedents and mediators of physical activity in endometrial cancer survivors: Increasing physical activity through steps to health. Health Psychol 34(10):1022-32, 2015. e-Pub 2015. PMID: 25642840.
116. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W, Gaffney DK. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer 121(13):2156-63, 2015. e-Pub 2015. PMID: 25847373.
117. Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated Port-Site Metastases After Minimally Invasive Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy. Int J Gynecol Cancer 25(5):869-74, 2015. e-Pub 2015. PMID: 25790043.
118. Gómez-Hidalgo NR, Darin MC, Dalton H, Jhingran A, Fleming N, Brown J, Ramirez PT. Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases. J Minim Invasive Gynecol 22(4):687-90, 2015. e-Pub 2015. PMID: 25772021.
119. Salcedo MP, Milbourne AM, Jhingran A, Eifel PJ, Ramirez PT, Schmeler KM. High-grade cervical dysplasia following radiation therapy for invasive cervical cancer: A report of four cases. Case Rep Oncol 8(2):217-21, 2015. e-Pub 2015. PMID: 26078740.
120. Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy 14(3):385-9, 2015. e-Pub 2015. PMID: 25620163.
121. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system?. Gynecol Oncol 136(2):269-73, 2015. e-Pub 2015. PMID: 25524458.
122. Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Jr SW. ACR Appropriateness Criteria Adjuvant Therapy in Vulvar Cancer. Oncology 29(11):867-875, 2015. e-Pub 2015.
123. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124(6):1098-104, 2014. e-Pub 2014. PMID: 25415160.
124. Martinez W, Thaker N, Jhingran A, Kuban DA. A radiation oncology peer review program for community hospitals. J Clin Oncol 32(30_suppl):200, 2014. e-Pub 2014. PMID: 28141415.
125. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W. Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 90(2):320-8, 2014. e-Pub 2014. PMID: 25304792.
126. Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W, Varia MA, Wahl AO, Yuh W, Gaffney DK, Radiation Oncology-Gynecology: EPO. ACR appropriateness Criteria® advanced stage endometrial cancer. Am J Clin Oncol 37(4):391-6, 2014. e-Pub 2014. PMID: 24977691.
127. Abu-Rustum N, Chi D, Coleman RL, del Campo JM, Fotopoulou C, Frumovitz M, Gershenson DM, Gonzalez A, Jhingran A, Ledermann J, Mariani A, Mirza M, Oaknin A, Ramirez PT, Schmeler KM, Sood AK. Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol 134(1):6-9, 2014. e-Pub 2014. PMID: 24952408.
128. Sun C, Brown AJ, Jhingran A, Frumovitz M, Ramondetta L, Bodurka DC. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer 24(6):1077-84, 2014. e-Pub 2014. PMID: 24905618.
129. Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W. Radiation Therapy Oncology Group Gynecologic Oncology Working Group: Comprehensive Results. Int J Gynecol Cancer 24(5):956-62, 2014. e-Pub 2014. PMID: 24819663.
130. Basen-Engquist K, Carmack C, Brown J, Jhingran A, Baum G, Song J, Scruggs S, Swartz MC, Cox MG, Lu KH. Response to an exercise intervention after endometrial cancer: Differences between obese and non-obese survivors. Gynecol Oncol 133(1):48-55, 2014. e-Pub 2014. PMID: 24680591.
131. Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer. Int J Radiat Oncol Biol Phys 88(2):357-62, 2014. e-Pub 2014. PMID: 24411609.
132. Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, Macapinlac HA, Leblanc E, Martinez A, Ramirez PT. Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): A phase III clinical trial comparing surgical to radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol 21(1):3-8, 2014. e-Pub 2014. PMID: 23911560.
133. Small W, Bosch WR, Strauss JB, Albuquerque K, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles TW, Jhingran A, Klopp AH, Kunos C, Mell LK, Powell M, Viswanathan AN, Yashar CM, Gaffney D. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer - an update. Int J Radiat Oncol Biol Phys 90(S1):S109, 2014. e-Pub 2014.
134. Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol 131(3):645-9, 2013. e-Pub 2013. PMID: 23643871.
135. Basen-Engquist K, Carmack CL, Li Y, Brown J, Jhingran A, Hughes DC, Perkins HY, Scruggs S, Harrison C, Baum G, Bodurka DC, Waters A. Social cognitive theory predictors of exercise behavior in endometrial cancer survivors. Health Psychol 32(11):1137-48, 2013. e-Pub 2013. PMID: 23437853.
136. Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly Cisplatin or every-3-week Cisplatin and 5-Fluorouracil. Int J Gynecol Cancer 23(8):1520-1527, 2013. e-Pub 2013. PMID: 24257567.
137. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-Field Radiation Therapy for Locoregionally Recurrent Ovarian Cancer. Gynecol Oncol 130(2):300-305, 2013. e-Pub 2013. PMID: 23648467.
138. Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR, Radiation Oncology-Gynecology: EPO. ACR Appropriateness Criteria® Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva. Am J Clin Oncol 36(4):415-422, 2013. e-Pub 2013. PMID: 23872794.
139. Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, Nuanjing J, D'Souza D, Souhami L, Small W, Gaur R, Jhingran A. Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer. Int J Radiat Oncol Biol Phys 86(1):83-90, 2013. e-Pub 2013. PMID: 23582248.
140. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol 129(2):304-9, 2013. e-Pub 2013. PMID: 23385150.
141. Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer 23(4):615-21, 2013. e-Pub 2013. PMID: 23552804.
142. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol 3(2):115-123, 2013. e-Pub 2013. PMID: 24674314.
143. Wagner A, Jhingran A, Gaffney D. Intensity Modulated Radiotherapy in Gynecologic Cancers: Hope, Hype or Hyperbole?. Gynecol Oncol. e-Pub 2013. PMID: 23632209.
144. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer. Int J Radiat Oncol Biol Phys 85(4):1045-50, 2013. e-Pub 2013. PMID: 23332221.
145. Fontanilla HP, Kelly P, Jhingran A, Iyer RB, Levenback C, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of FDG-avid paraaortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. e-Pub 2013.
146. Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3(1):e21-8, 2013. e-Pub 2013. PMID: 24674269.
147. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol 3(1):45-53, 2013. e-Pub 2013. PMID: 24674263.
148. Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM. COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and Celecoxib: A quantitative immunohistochemical analysis of RTOG C0128. Int J Gynecol Cancer 23(1):176-183, 2013. e-Pub 2013. PMID: 23221733.
149. Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Planning Meeting TG[AOBOTPOTSGECCT. Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: Taking Endometrial Cancer Trials Into the Translational Era. Int J Gynecol Ca 23(8):1528-1534, 2013. e-Pub 2013.
150. Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, Souhami L, Small W, Berk L, Gaffney D. A phase II study of intensity-modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation Therapy Oncology Group trial 0418. Int J Radiat Oncol Biol Phys 84(1):e23-8, 2012. e-Pub 2012. PMID: 22543211.
151. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: Implications for surgical staging. Int J Gynecol Cancer 22(7):1203-7, 2012. e-Pub 2012. PMID: 22810967.
152. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-7, 2012. e-Pub 2012. PMID: 21640510.
153. Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Jr SW, Gaffney D, Viswanathan AN, Michalski JM. Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. e-Pub 2012. PMID: 22483697.
154. Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys 82(1):256-62, 2012. e-Pub 2012. PMID: 21093170.
155. Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P, Society AB. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy 11(1):53-7, 2012. e-Pub 2012. PMID: 22265438.
156. Jr SW, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK. ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. Am J Clin Oncol 35(4):399-405, 2012. e-Pub 2012. PMID: 22810416.
157. Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report. Gynecol Oncol Reports 2:9-10, 2012. e-Pub 2012.
158. Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small, Jr W, Yashar CM, Yuh W, Cardenes HR. ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. International Journal of Gynecological Cancer. e-Pub 2011. PMID: 22155418.
159. Fisher CM, Fortenberry BR, Jhingran A, Eifel PJ. Novel technique for simulation and external beam treatment planning for obese patients. Pract Radiat Oncol 1(3):152-155, 2011. e-Pub 2011. PMID: 24673944.
160. Sharp HJ, Pinnix CC, Jhingran A, Euscher ED, Rohren EM, Ramirez PT. PET/CT in a patient with adenoma malignum of the uterine cervix. Clin Nucl Med 36(6):468-469, 2011. e-Pub 2011. PMID: 21552028.
161. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: A prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 117(9):1928-1934, 2011. e-Pub 2011. PMID: 21509770.
162. Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR. ACR Appropriateness Criteria® on advanced cervical cancer expert panel on radiation oncology-gynecology. Int J Radiat Oncol Biol Phys. e-Pub 2011. PMID: 21215531.
163. Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Jr SW, Varia MA, Zelop CM, Women's Imaging AEPO, Oncology-Gynecology R. ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q 27(2):139-145, 2011. e-Pub 2011. PMID: 21606818.
164. Small W, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of RTOG 0116. Int J Gynecol Ca 21(7):1266-1275, 2011. e-Pub 2011. PMID: 21892091.
165. Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report. Gynecol Oncol Case Rep 2(1):9-10, 2011. e-Pub 2011. PMID: 24371600.
166. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor Kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys 78(5):1331-6, 2010. e-Pub 2010. PMID: 20231067.
167. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-5, 2010. e-Pub 2010. PMID: 20837355.
168. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De Los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Consortium GI. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. e-Pub 2010. PMID: 20472347.
169. Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 76(5):1396-403, 2010. e-Pub 2010. PMID: 19581056.
170. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: Implications for survivors. Cancer 116(3):625-630, 2010. e-Pub 2010. PMID: 20052724.
171. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115(1):6-11, 2009. e-Pub 2009. PMID: 19632709.
172. Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF, Levenback CF, Jhingran A, Parker C, Munsell MF, Smith JA. Evaluation of intervention to prevent hypomagnesaemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer 17(9):1195-201, 2009. e-Pub 2009. PMID: 19172305.
173. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: Does marital status matter?. Int J Gynecol Cancer 19(6):1107-12, 2009. e-Pub 2009. PMID: 19820377.
174. Weidhaas JB, Li SX, Winter K, Ryu J, Jhingran A, Miller B, Dicker AP, Gaffney D. Changes in gene expression predicting local control in cervix cancer: Results from RTOG 0128. Clin Cancer Res 15(12):4199-4206, 2009. e-Pub 2009. PMID: 19509178.
175. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):288.e1-8, 2009. e-Pub 2009. PMID: 19110220.
176. Beadle BM, Jhingran A, Salehpour M, Sam M, Iyer RB, Eifel PJ. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 73(1):235-41, 2009. e-Pub 2009. PMID: 18513882.
177. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 19(1):2-7, 2009. e-Pub 2009. PMID: 19258933.
178. Kitchener HC, Trimble EL, Cancer Intergroup ECWGOTG. Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1):134-140, 2009. e-Pub 2009. PMID: 19258955.
179. Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol 112(4):899-905, 2008. e-Pub 2008. PMID: 18827134.
180. Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for the delineation of the clinical target volume for intensity modulated pelvic radiotherapy in the postoperative treatment of endometrial cancer. Int J Radiat Oncol Biol Phys 71(2):428-434, 2008. e-Pub 2008. PMID: 18037584.
181. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 71(1):226-36, 2008. e-Pub 2008. PMID: 18406887.
182. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478-481, 2008. e-Pub 2008. PMID: 18190952.
183. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1):118-25, 2008. e-Pub 2008. PMID: 17869451.
184. Ramondetta LM, Jhingran A. Eleven years: The long and winding road. Gynecol Oncol 107(2):166-168, 2007. e-Pub 2007. PMID: 17950382.
185. Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68(4):1081-1087, 2007. e-Pub 2007. PMID: 17398031.
186. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-479, 2007. e-Pub 2007. PMID: 17292459.
187. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan RJ, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Soper J, Teng N, Cancer Network NC. Uterine cancers. J Natl Compr Canc Netw 4(5):438-62, 2006. e-Pub 2006. PMID: 16687093.
188. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol 103(2):547-53, 2006. e-Pub 2006. PMID: 16730784.
189. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 16(3):1106-11, 2006. e-Pub 2006. PMID: 16803493.
190. Iyer R, Jhingran A. Radiation injury: Imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging 31(6):S131-9, 2006. e-Pub 2006. PMID: 17114067.
191. Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback C. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol 15(2):79-83, 2006. e-Pub 2006. PMID: 17035002.
192. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD. Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63(5):1508-13, 2005. e-Pub 2005. PMID: 16169678.
193. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: A Monte Carlo study. Phys Med Biol 50(21):5075-87, 2005. e-Pub 2005. PMID: 16237242.
194. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 2005. e-Pub 2005. PMID: 16234510.
195. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 63(2):615-21, 2005. e-Pub 2005. PMID: 16168853.
196. Solin LJ, Fourquet A, Vicini FA, Taylor M, Haffty B, Strom EA, Wai E, Pierce LJ, Marks LB, Bartelink H, Campana F, McNeese MD, Jhingran A, Olivotto IA, Bijker N, Hwang WT. Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 41(12):1715-23, 2005. e-Pub 2005. PMID: 16043350.
197. Ahamad A, D'Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ. Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117-24, 2005. e-Pub 2005. PMID: 15990017.
198. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 2005. e-Pub 2005. PMID: 15850913.
199. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138-47, 2005. e-Pub 2005. PMID: 15850914.
200. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61(4):1062-1070, 2005. e-Pub 2005. PMID: 15752885.
201. Solin LJ, Fourquet A, Vicini FA, Taylor M, Olivotto IA, Haffty B, Strom EA, Pierce LJ, Marks LB, Bartelink H, McNeese MD, Jhingran A, Wai E, Bijker N, Campana F, Hwang WT. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103(6):1137-46, 2005. e-Pub 2005. PMID: 15674853.
202. Tangjitgamol S, Ramirez PT, Sun CC, See HT, Jhingran A, Kavanagh JJ, Deavers MT. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer 15(4):646-56, 2005. e-Pub 2005. PMID: 16014119.
203. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: Implications for adjuvant therapy. Int J Gynecol Cancer 15(3):510-6, 2005. e-Pub 2005. PMID: 15882178.
204. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93(1):27-33, 2004. e-Pub 2004. PMID: 15047210.
205. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58(3):786-96, 2004. e-Pub 2004. PMID: 14967435.
206. Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, Jhingran A, Eifel P, Montz F, Wharton JT. Innovations in the treatment of invasive cervical cancer. Cancer 98(Suppl 9):2052-2063, 2003. e-Pub 2003. PMID: 14603542.
207. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57(2):409-18, 2003. e-Pub 2003. PMID: 12957252.
208. Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 90(3):625-8, 2003. e-Pub 2003. PMID: 13678736.
209. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets. Gynecol Oncol 90(3):529-36, 2003. e-Pub 2003. PMID: 13678720.
210. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56(5):1366-72, 2003. e-Pub 2003. PMID: 12873682.
211. Kabbani W, Deavers MT, Malpica A, Burke TW, Liu J, Ordoñez NG, Jhingran A, Silva EG. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol 22(3):297-302, 2003. e-Pub 2003. PMID: 12819400.
212. Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J 9(1):33-41, 2003. e-Pub 2003. PMID: 12602766.
213. Jhingran A, Kim JS, Buchholz TA, Katz A, Strom EA, Hunt KK, Sneige N, McNeese MD. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 54(3):804-9, 2002. e-Pub 2002. PMID: 12377332.
214. Munkarah AR, Jhingran A, Iyer RB, Wallace S, Eifel PJ, Gershenson D, Burke TW. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer 12(6):755-9, 2002. e-Pub 2002. PMID: 12445255.
215. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20(17):3651-7, 2002. e-Pub 2002. PMID: 12202666.
216. Iyer RB, Jhingran A, Sawaf H, Libshitz HI. Imaging findings after radiotherapy to the pelvis. AJR Am J Roentgenol 177(5):1083-9, 2001. e-Pub 2001. PMID: 11641175.
217. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18(15):2817-27, 2000. e-Pub 2000. PMID: 10920129.
218. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 46(5):1177-83, 2000. e-Pub 2000. PMID: 10725629.
219. Buchholz TA, Tucker SL, Moore RA, McNeese MD, Strom EA, Jhingrin A, Hortobagyi GN, Singletary SE, Champlin RE. Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. Int J Radiat Oncol Biol Phys 46(2):337-343, 2000. e-Pub 2000. PMID: 10661340.
220. Verstovsek S, Verschraegen CF, Edwards CL, Malpica A, Kavanagh JJ, Ross MI, Strom EA, Jhingran A, Theriault RL, Kudelka AP. Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference]. Am J Clin Oncol 23(1):99-103, 2000. e-Pub 2000. PMID: 10683089.
221. Jhingran A. Utility of positron emission tomography combined with computed tomography in a patient with adenoma malignum of the uterine cervix: A case report. Gynecologic Oncology.

Invited Articles

1. Jeffery DD, BarberaL, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE. Self-reported sexual function measures administered to female cancer patients: A systemic review 2008-2014. Journal of Psychosocial Oncology, 2015. e-Pub 2015.
2. Frumovitz M, Jhingran A, Schmeler KM. Early-stage cervical cancer: Treatment choices vary according to disease stage and patient-specific factors. OncoLog 57(7), 2012. e-Pub 2012.
3. Bhosale P, Iyer R, Jhingran A, Podoloff D. PET/CT imaging in gynecologic malignancies other than ovarian and cervical cancer. PET Clin 5(4):463-475, 2010. e-Pub 2010. PMID: 27157973.
4. Jhingran A. Technical advances in radiation oncology for the treatment of cervical carcinoma. Revista de Ginecologia Oncologica 3:18-26, 2008. e-Pub 2008.
5. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol 16(3):144-51, 2006. e-Pub 2006. PMID: 16814154.
6. Jhingran A. The Shivnani/Rimel/Schink/Small article reviewed: Cancer of the cervix: Current management and new approaches. Oncology 20(12):3, 2006. e-Pub 2006.
7. Ahamad A, Jhingran A. New radiation techniques in gynecological cancer. Int J Gynecol Cancer 14(4):569-79, 2004. e-Pub 2004. PMID: 15304149.

Review Articles

1. Anakwenze, C, Ewongwo, A, Onyewadume, L, Oyekan, A, Chigbo, CO, Valle, LF, Geng, Y, Olapade, P, Okwunze, K, Lasebikan, N, Jhingran, A, Balogun, OD, Ntekim, A. A systematic review of endometrial cancer clinical research in Africa. Infectious Agents and Cancer 19(1), 2024. e-Pub 2024. PMID: 38217018.
2. Anakwenze CP, Ewongwo A, Onyewadume L, Oyekan A, Chigbo CO, Valle L, Geng Y, Olapade P, Okwunze K, Lasebikan N, Jhingran A, Balogun OD, Ntekim A. A systematic review of endometrial cancer clinical research in Africa. Infect Agent Cancer 19(1):2, 2024. e-Pub 2024. PMID: 38217018.
3. Viveros-Carreño D, Vieira-Serna S, Grillo-Ardila CF, Rodriguez J, Mora-Soto N, Jhingran A, Ramirez PT, Pareja R. Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review. Int J Gynecol Cancer 33(7):1057-1062, 2023. e-Pub 2023. PMID: 37192760.
4. Court L, Aggarwal A, Burger H, Cardenas C, Chung C, Douglas R, du Toit M, Jaffray D, Jhingran A, Mejia M, Mumme R, Muya S, Naidoo K, Ndumbalo J, Nealon K, Netherton T, Nguyen C, Olanrewaju N, Parkes J, Shaw W, Trauernicht C, Xu M, Yang J, Zhang L, Simonds H, Beadle BM. Addressing the Global Expertise Gap in Radiation Oncology: The Radiation Planning Assistant. JCO Glob Oncol 9:e2200431, 2023. e-Pub 2023. PMID: 37471671.
5. Woopen, H, Sehouli, J, Davis, A, Lee, YC, Cohen, PA, Ferrero, A, Gleeson, N, Jhingran, A, Kajimoto, Y, Mayadev, J, Barretina-Ginesta, MP, Sundar, S, Suzuki, N, van Dorst, E, Joly, F. GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer. Cancer treatment reviews 107, 2022. e-Pub 2022. PMID: 35525106.
6. Sapienza LG, Thomas JJ, Showalter TN, Echeverria AE, Ludwig MS, Chen AC, Jo E, Calsavara VF, Hilsenbeck SG, Jhingran A, Frumovitz MM, Baiocchi G. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal. Gynecol Oncol 165(3):642-649, 2022. e-Pub 2022. PMID: 35410732.
7. Jhingran A. Updates in the treatment of vaginal cancer. Int J Gynecol Cancer 32(3):344-351, 2022. e-Pub 2022. PMID: 35256422.
8. Small W, Peltecu G, Puiu A, Corha A, Cocîr?a E, Cigaran RG, Plante M, Jhingran A, Stang K, Gaffney D, Bacon M, McCormack M. Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference. Int J Gynecol Cancer. e-Pub 2020. PMID: 33122244.
9. Rhee DJ, Jhingran A, Kisling K, Cardenas C, Simonds H, Court L. Automated Radiation Treatment Planning for Cervical Cancer. Semin Radiat Oncol 30(4):340-347, 2020. e-Pub 2020. PMID: 32828389.
10. Elshaikh MA, Modh A, Jhingran A, Biagioli MC, Coleman RL, Gaffney DK, Harkenrider MM, Heskett K, Jolly S, Kidd E, Lee LJ, Li L, Portelance L, Sherertz T, Venkatessan AM, Wahl AO, Yashar CM, Small W. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecol Oncol. e-Pub 2020. PMID: 32475772.
11. Lin LL, Lakomy DS, Ning MS, Simpkins F, Jhingran A. Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin. Int J Gynecol Cancer 30(4):409-423, 2020. e-Pub 2020. PMID: 32193219.
12. Damast S, Jeffery DD, Son CH, Hasan Y, Carter J, Lindau ST, Jhingran A. Literature Review of Vaginal Stenosis and Dilator Use in Radiation Oncology. Pract Radiat Oncol. e-Pub 2019. PMID: 31302301.
13. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet 393(10167):169-182, 2019. e-Pub 2019. PMID: 30638582.
14. Small W, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney DK. Cervical cancer: A global health crisis. Cancer 123(13):2404-2412, 2017. e-Pub 2017. PMID: 28464289.
15. Grover S, Xu M, Jhingran A, Mahantshetty U, Chuang L, Small W, Gaffney D. Clinical trials in low and middle-income countries - Successes and challenges. Gynecol Oncol Rep 19:5-9, 2017. e-Pub 2017. PMID: 28004030.
16. Wahl AO, Gaffney DK, Jhingran A, Yashar CM, Biagioli M, Elshaikh MA, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Williams NL, Small W. ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer. Oncology (Williston Park) 30(9):816-22, 2016. e-Pub 2016. PMID: 27633412.
17. Lindau ST, Abramsohn EM, Baron SR, Florendo J, Haefner HK, Jhingran A, Kennedy V, Krane MK, Kushner DM, McComb J, Merritt DF, Park JE, Siston A, Straub M, Streicher L. Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist. CA Cancer J Clin 66(3):241-63, 2016. e-Pub 2016. PMID: 26784536.
18. Jeffery DD, Barbera L, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE. Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014. J Psychosoc Oncol 33(4):433-66, 2015. e-Pub 2015. PMID: 25997102.
19. Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK. ACR appropriateness criteria management of vaginal cancer. Oncology (Williston Park) 27(11):1166-73, 2013. e-Pub 2013. PMID: 24575547.
20. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91(3):463-9, 2003. e-Pub 2003. PMID: 14675663.
21. Hogberg T, Fredstorp M, Jhingran A. Indications for adjuvant radiotherapy in endometrial carcinoma. Hematol Oncol Clin North Am 13(1):189-209, 1999. e-Pub 1999. PMID: 10080076.

Professional Educational Materials

1. Monk BJ, Coleman RL, Herzog TJ, Jhingran A, Wright TC. Cases in Advanced Gynecological Cancers: A Virtual Tumor Board, Meniscus Educational Institute Website, 2005.

Other Articles

1. Woopen, H, Sehouli, J, Davis, A, Lee, YC, Cohen, PA, Ferrero, A, Gleeson, N, Jhingran, A, Kajimoto, Y, Mayadev, J, Barretina-Ginesta, MP, Sundar, S, Suzuki, N, van Dorst, E, Joly, F Erratum to “GCIG-Consensus guideline for long-term survivorship in gynecologic cancer. Cancer treatment reviews 109, 2022. PMID: 35803179.

Editorials

1. Jhingran A. Is team management appropriate for a patient receiving coronary brachytherapy?. Int J Radiat Oncol Biol Phys 57(1):3, 2003. PMID: 12909206.

Abstracts

1. Chapman, BV, Swanick, CW, Ning, MS, Allen, PK, Soliman, PT, Westin, SN, Pardeshi, V, Broaddus, RR, Lu, KH, Jhingran, A, Eifel, PJ, Klopp, AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and Check for updates non-endometrioid endometrial cancer. GYNECOLOGIC ONCOLOGY 154(1):22-28, 2019. e-Pub 2019. PMID: 31109659.
2. Swanick CW, Castle KO, Cunningham MG, Vedam S, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Impact of normal tissue motion on dose to critical structures during intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 90(S1):S482, 2014. e-Pub 2014.
3. Takiar V, Burks JK, Sulman EP, Ramondetta LM, Jhingran A, Deavers MT, Eifel PJ, Klopp AH. PD-1 levels correlate with lymph node positivity in patients with squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 90(S1):S479, 2014. e-Pub 2014.
4. Thaker N, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with pelvic lymph node-positive stage IVB vulvar cancer: Time to reconsider the FIGO staging system?. Int J Radiat Oncol Biol Phys 87(2S):S129, 2013. e-Pub 2013.
5. Koay EJ, Jhingran A, Klopp AH, Levenback CF, Eifel PJ. Factors associated with long-term survival in locally-advanced squamous cell carcinoma of the vulva treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 87(2S):S129, 2013. e-Pub 2013.
6. Klopp AH, Jhingran A, Juloori A, Perinjelil V, Broaddus R, Lu K, Eifel PJ. Management of Node-positive endometrial cancer with multimodality adjuvant therapy. Int J Radiat Oncol Biol Phys 84(3S):S455, 2012. e-Pub 2012.
7. Hashem R, Winter K, Ruo R, Portelance L, Jhingran A, Demas W, Jacobson GM, Gaffney D. Defining the impact of the use of oral contrast in pelvic intensity modulated radiation therapy (IMRT) – an RTOG 0418 secondary analysis. Int J Radiat Oncol Biol Phys 84(3S):S18, 2012. e-Pub 2012.
8. Koay EJ, Jhingran A, Klopp AH, Levenback CF, Eifel PJ. Definitive radiation therapy of locally advanced squamous cell carcinoma of the vulva: Factors associated with vulvar disease control. Int J Radiat Oncol Biol Phys 84(3S):S460, 2012. e-Pub 2012.
9. Juloori A, Klopp A, Ramondetta L, Jhingran A, Euscher E, Fleming N, Lu KJ, Eifel PJ. Radiation therapy in the management of carcinosarcoma of the uterus. Int J Radiat Oncol Biol Phys 84(3S):S456, 2012. e-Pub 2012.
10. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally confined ovarian cancer. Int J Radiat Oncol Biol Phys 84(3S):S96, 2012. e-Pub 2012.
11. Portelance L, Moughan J, Jhingran A, Miller BE, Salehpour MR, D'Souza D, Haddock M, Rotman M, Gaffney DK. A phase II multi-institutional study of postoperative pelvic intensity modulated radiation therapy (IMRT) with weekly cisplatin in patients with cervical carcinoma: Two year efficacy results of the RTOG 0418. Int J Radiat Oncol Biol Phys 81(2, Suppl):S3, 2011. e-Pub 2011.
12. Fisher CM, Klopp AH, Jhingran A, Vera R, Levenback C, Eifel PJ. Vaginal cancer outcomes using intensity modulated radiation therapy for definitive treatment at UT MD Anderson Cancer Center. Int J Radiat Oncol Biol Phys 81(2, Suppl):S480, 2011. e-Pub 2011.
13. Verma J, Klopp AH, Jhingran A, Hildebrandt E, Tucker S, Eifel PJ. Dosimetric predictors of duodenal toxicity following IMRT to para-aortic nodes. Int J Radiat Oncol Biol Phys 81(2, Suppl):S473, 2011. e-Pub 2011.
14. Klopp AH, Jhingran A, Pardeshi V, Schmeler K, Bodurka D, Lu K, Eifel PJ. Chemoradiation therapy followed by adjuvant chemotherapy for management of stage IIIC2 endometrial cancer. Int J Radiat Oncol Biol Phys 81(2, Suppl):S191, 2011. e-Pub 2011.
15. Shirvani SM, Klopp AH, Jhingran A, Lu KH, Soliman PT, Eifel PJ. Intensity modulated radiotherapy for definitive treatment of para-aortic relapse in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 81(2, Suppl):S190, 2011. e-Pub 2011.
16. Fontanilla HP, Klopp AH, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Distribution of para-aortic lymph nodes in cervical cancer. Int J Radiat Oncol Biol Phys 81(2, Suppl):S187, 2011. e-Pub 2011.
17. Jhingran A, Winter K, Portelance L, Miller BE, Salehpour MR, Gaur R, Souhami L, Small W, Gaffney D. Efficacy and safety of IMRT after surgery in patients with endometrial cancer: RTOG 0418 phase II study. Int J Radiat Oncol Biol Phys 81(2, Suppl):S45, 2011. e-Pub 2011.
18. Patel H, Klopp AH, Jhingran A, Lindberg ME, Iyer RB, Kelly P, Zhang Y, Dong L, Eifel PJ. Mapping location of PET positive lymph nodes in cervical cancer. Int J Radiat Oncol Biol Phys 78(3):S143, 2010. e-Pub 2010.
19. Sulman EP, Eifel PJ, Jhingran A, Aldape KD, Deavers MT, Klopp AH. Podoplanin expression is prognostic for survival of patients with squamous cell carcinoma of the cervix treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 75(3):S370, 2009. e-Pub 2009.
20. Klopp AH, Jhingran A, Eifel PJ, Deavers MT, Sulman EP. Galectin-7 is a prognostic factor for radiation response in squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 75(3):S365, 2009. e-Pub 2009.
21. Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Diaz R, Magliocco AM. Low COX-2 expression, but not CD34, predicts for worse overall survival in patients with locally-advanced cervical cancer treated with chemoradiotherapy and celecoxib: A comparative immunohistochemical analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 75(3):S150, 2009. e-Pub 2009.
22. Schmeler K, Jhingran A, Iyer R, Sun C, Eifel P, Soliman P, Ramirez P, Frumovitz M, Bodurka D, Sood A. Pelvic fractures following radiation therapy for cervical cancer: Implications for survivors. Proceedings of the 2008 Annual Meeting for the Felix Rutledge Society, 2008, 2008. e-Pub 2008.
23. Jhingran A, Winter K, Portelance L, Miller BE, Salehpour M, Gaur R, Souhami L, Small W, Berk LB, Gaffney D. A phase II study of intensity modulated radiation therapy (IMRT) to the pelvic for post-operative patients with endometrial carcinoma (RTOG 0418). Int J Rad Oncol Biol Phys 72(1, Suppl):S16, 2008. e-Pub 2008.
24. Weidhaas JB, Li S, Winter K, Ryu J, Jhingran A, Miller B, Dicker A, Gaffney D. Changes in gene expression predicting local control in cervical cancer: Results from RTOG 0128. Int J Radiat Oncol Biol Phys 72(1, Suppl):S16, 2008. e-Pub 2008.
25. Small W, Winter K, Levenback C, Iyer R, Hymes S, Jhingran A, Gaffney D, Erickson B, Greven K. Extended field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of Arm 2 of RTOG 0116. Int J Radiat Oncol Biol Phys 69(3):S5, 2007. e-Pub 2007.
26. Beadle BM, Jhingran A, Salehpour M, Sam M, Eifel PJ. Tumor Regression and Organ Motion During the Course of Chemoradiation for Cervical Cancer: Implications for Treatment Planning and Use of IMRT. Int J Radiat Oncol Biol Phys 66(3):S44, 2006. e-Pub 2006.
27. Eifel PJ, Klopp A, Ramondetta LM, Gershenson DM, Jhingran A. Node-positive Adenocarcinoma of the Endometrium: Outcome and Patterns of Recurrence. Int J Radiat Oncol Biol Phys 66(3):S166, 2006. e-Pub 2006.
28. Eifel P, Levenback C, Jhingran A, Thames H. Predictive Value of a Proposed Subclassification of Stage I and II Cervical Cancer Using Clinical Tumor Diameter. Gyn Oncol 101(1, Suppl 1):S181, 2006. e-Pub 2006.
29. Price M, Gifford K, Horton J, Eifel P, Lawyer A, Jhingran A, and Mourtada F. Comparison of LDR to PDR Dose Distributions: A Monte Carlo Study. Medical Physics 32(6):2098, 2005. e-Pub 2005.
30. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary Adenocarcinoma of the Vagina. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S215, 2005. e-Pub 2005.
31. Jhingran A. Concurrent Chemoradiation in the Routine Management of Patients With Cervical Cancer: How Does the Experience Compare With Treatment on a Prospective Randomized Trial?. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S95, 2005. e-Pub 2005.
32. Eifel PJ, Jhingran AColeman R, Thames HD. Is Anemia a Cause of Radiation Treatment Failure in Patients With Squamous Carcinoma of the Cervix?. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S94, 2005. e-Pub 2005.
33. Jhingran A. A Pilot Study to Evaluate Consistency of Bladder Filling and Vaginal Movement in Patients Receiving Pelvic IMRT. Proceedings of the 87th Annual Meeting of the American Radium Society, 2005. e-Pub 2005.
34. Gaffney DK, Winter K, Dikcer A, Miller B, Jhingran A, Ryu J, Avizonis V, Fromm M, Greven K. A phase I-II study of COX-2 inhibitor, Celebrex (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S93-94, 2005. e-Pub 2005.
35. Jhingran A, Yom SS, Zang X, Eifel PJ. Recurrence Above the Radiotherapy Field After Definitive Treatment of Cervix Cancer. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S217, 2005. e-Pub 2005.
36. Mell L, Fyles A, Small W, Creutzberg C, Jhingran A, Arcangeli G, Varia M, Hatano K, De Los Santos J, Barillot I, Roeske J, Mundt A. Adjuvant intensity modulated pelvic radiation therapy in gynecologic malignancies: Survey of the gynecologic IMRT working group. Int J Radiat Oncol Biol Phys 60(1):S215-6, 2004. e-Pub 2004.
37. Gifford KA, Lawyer AA, Jhingran A, Eifel PJ, Horton JL. Monte Carlo calculations around a commercial gynecological applicator. AAPM 2003 Annual Meeting, San Diego Medical Physics, 30(8):1470, 2003. e-Pub 2003.
38. Pelloski CE, Palmer MB, Chronowski GM, Horton JL, Jhingran A, Eifel PJ. CT-based volumetric dosimetry of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 57(2):S343-4, 2003. e-Pub 2003.
39. Strom E, Solin LJ, Vicini FA, Taylor ME, Olivotto IA, Haffty BG, Pierce LJ, Marks LB, Jhingran A, Wai ES, Bijker N, Harry B. Long-term results for women with mammographically detected ductal carcinoma in-situ of the breast treated with breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys 57(2):S240-1, 2003. e-Pub 2003.
40. Jhingran A, Levenback C, Katz A, Eifel PJ. Radiation therapy for vulvar carcinoma: predictors of vulvar recurrence. Int J Radiat Oncol Biol Phys 57(2):S193, 2003. e-Pub 2003.
41. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive treatment of vaginal cancer with radiation therapy. Int J Radiat Oncol Biol Phys 57(2):S194, 2003. e-Pub 2003.
42. Viswanathan A, Jhingran A, Deavers M, Ramirez P, Eifel PJ. Patterns of failure in small cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54(2):41, 2002. e-Pub 2002.
43. Ahamad A, Souza WD, Salehpour M, Iyer R, Thames H, Jhingran A, Eifel PJ. Intensity modulated radiation therapy (IMRT) for post-hysterectomy pelvic radiation: Selection of patients and planning target volume (PTV). Int J Radiat Oncol Biol Phys 54(2):42-43, 2002. e-Pub 2002.
44. Woodward WA, Katz A, Buchholz T, McNeese M, Perkins G, Jhingran A, Strom E. Patterns and predicators of locoregional recurrence in 469 patients treated with post-mastectomy radiation. Int J Radiat Oncol Biol Phys 54(2, Suppl 1):92, 2002. e-Pub 2002.
45. Jhingran A, Wiatrek R, Levenback C, Eifel PJ. Late complications of postoperative radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 51(3, Supp 1):216, 2001. e-Pub 2001.
46. Callister M, Jhingran A, Ramondetta L, Burke T, Eifel PJ. Malignant mixed millerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 51(Suppl 1):37-38, 2001. e-Pub 2001.
47. Katz A, Eifel PJ, Jhingran A, Levenback C. Radiotherapy results in excellent regional control for patients with squamous cell carcinoma (SCC) of the vulva. Int J Radiat Oncol Biol Phys 5(3, Suppl 1):38, 2001. e-Pub 2001.
48. Katz A, Strom EA, Buchholz TA, Jhingran A, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 48(3, Suppl 1):141-142, 2000. e-Pub 2000.
49. Fossella FV, Zinner RG, Komaki R, Jung M, Jhingran A, Glisson BS, Pisters KM, Stevens CW, Khuri FR, Kurie JM, et al. Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with Gemcitabine plus Cisplatin (CDDP): A phase I trial for patients with stage III non-small cell lung cancer (NSCLC). Lung Cancer 29(1, Suppl 1):111-112, 2000. e-Pub 2000.
50. Eifel PJ, Jhingran A, Atkinson HN, Bodurka-Bevers D. The influence of smoking history and other patient characteristics on the risk of major complications after radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 48(3, Suppl 1):212, 2000. e-Pub 2000.
51. Zinner R, Fossella FV, Komaki R, Delclos M, Jung M, Glisson BS, Lee JS, Pisters K, Jhingran A, Hong WK. Phase I trial of concurrent gemcitabine (G) plus chest radiotherapy (XRT), followed by consolidation systemic chemotherapy with G plus cisplatin (CDDP), for patients with stage III and medically inoperable stage II non-small cell lung cancer (NSCLC). J Clin Oncol (ASCO 35th Annual Meeting) 18:466a, 1999. e-Pub 1999.
52. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 42(5):151, 1998. e-Pub 1998. PMID: 10725629.

Book Chapters

1. Jhingran, A, Sims, TT. Endometrial Cancer, 271-283, 2024.
2. Anastasio, MK, Jhingran, A, Sims, TT. Cervical Cancer, 258-270, 2024.
3. Jhingran, A, Meyer, LA. Malignant diseases of the cervix, 674 and 690.e3, 2021.
4. Smith, JA, Jhingran, A. Principles of radiation therapy and chemotherapy in gynecologic cancer, 618 and 636.e1, 2021.
5. Burke TW, Jhingran A, Lu K, and Broaddus R. Endometrial Cancer. In: 60 years of survival outcomes at the University of Texas MD Anderson Cancer Center. Springer, 109-117, 2013.
6. Jhingran A, Shaaban AM. Ovary and Fallopian Tube. In: Radiation Oncology Imaging and Treatment. 1st. Amirsys Publishing, Inc, 54-75, 2013.
7. Jhingran A, Russell AH, Seiden MV, Duska LR, Goodman AK, Lee SI, Digumarthy SR, Fuller Jr AF. Cancers of the cervix, Vulva, and Vagina. In: Clinical Oncology. 5th. Elsevier Churchill Livingstone, 1534-1574, 2013.
8. Klopp A, Jhingran A. Field cancerization in vulvar, vaginal, and cervical epithelia. In: Field Cancerization: Basic Science and Clinical Applications. Nova Science Publishers, Inc, 415-421, 2011.
9. Jhingran A, Eifel PJ. The endometrium. In: Radiation Oncology. 9th. Mosby, 774-797, 2010.
10. Jhingran A. Neoplasms of the cervix. In: Cancer Medicine. 8th. People's Medical Publishing House - USA, 1299-1324, 2010.
11. Jhingran A. The ovary. In: Radiation Oncology. 9th. Mosby, 812-832, 2010.
12. Jhingran A, Eifel PJ. Radiation therapy for cervical carcinoma. In: Gynecology & Obstetrics. Global Library of Women's Medicine, 2008.
13. Jhingran A. Predictors of radiation sensitivity and resistance. In: Prognostic and Predictive Factors in Gynecologic Cancer. Taylor & Francis Medical Books, 259-267, 2007.
14. Jhingran A, Levenback C. Malignant diseases of the cervix. In: Comprehensive Gynecology. 5th. Mosby, 759-780, 2007.
15. Brown J, Jhingran A, Deavers M, Markman M. Stromal tumors of the ovary. In: Textbook of Uncommon Cancer. 3rd. John Wiley and Sons, Ltd, 455-466, 2006.
16. Ramondetta LM, Bodurka DC, Deavers MT, Jhingran A. Uterine sarcomas. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Springer-Verlag, 125-147, 2006.
17. Jhingran A, Eifel PJ, Ramirez PT. Treatment of locally advanced cervical cancer. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Springer-Verlag, 102-124, 2006.
18. Jhingran A, Eifel PJ, Wharton JT, Totolero-Luna G. Neoplasms of the cervix. In: Cancer Medicine. 7th. BC Decker Inc, 1497-1521, 2006.
19. Ramondetta LM, Burke TW, Broaddus R, Jhingran A. Treatment of endometrial cancer. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Springer-Verlag, 148-174, 2006.
20. Jhingran A, Salehpour M, Brooks B. Endometrial cancer. In: Intensity Modulated Radiation Therapy: A Clinical Perspective. BC Decker, 513-517, 2005.
21. Jhingran A. Gynecologic cancers. In: Practical Essential of Intensity Modulated Radiation Therap. Lippincott Williams and Wilkins, 325-351, 2005.
22. Jhingran A, Eifel PJ, Wharton JT, Tortolero-Luna G. Neoplasms of the cervix. In: Cancer Medicine. 6th. B. C. Decker, Inc, 1779-1808, 2003.
23. Jhingran A, Eifel PJ. Cancer of the endometrium. In: Radiation Oncology. 8th. Mosby, 724-742, 2003.
24. Jhingran A, Eifel PJ. Radiation therapy. In: Handbook of Gynecologic Oncology. Martin Dunitz Ltd, 77-90, 2002.
25. Jhingran A, Eifel PJ. Radiation therapy for invasive cervical cancer. In: ACS Atlas of Oncology: Cervix, Vulva and Vagina. B. C. Decker, Inc, 147-168, 2001.
26. Jhingran A, Eifel PJ. Radiotherapy. In: Gynecologic Oncology Handbook. Martin Dunitz Ltd, 73-87, 2000.
27. Jhingran A, Eifel PJ. The role of radiotherapy in the management of vulvar cancer. In: Cancer and Precancer of the Vulva. Thomson Science & Professional, 120-134, 2000.
28. Jhingran A. Radiation treatment of cervical cancer. In: Cervical Cancer. Future Science Group.
29. Jhingran A, Burke T. Cervix. In: MD Anderson Cancer Center Survival Monograph.

Books (edited and written)

1. Jhingran A, Levenback C. Biology and Management of Cervical Carcinoma. Humana Press.

Letters to the Editor

1. Kouzy R, Ludmir EB, Hoffman KE, Jhingran A, Kuban DA. In Reply to Akhtar et al. Pract Radiat Oncol 14: 466-467, 2024.

Patents

1. Adaptive Intracavitary Brachytherapy Applicator for Cervical Cancer. Patent Number: MDA04-056.